Average Insider

Where insiders trade, we follow

$BOLD
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California.
Healthcare
Sector
Biotechnology
Industry
Zachary Hornby
CEO
64
Employees
$2.48
Current Price
$29.33M
Market Cap
52W Low$0.96
Current$2.4883.1% above low, 16.9% below high
52W High$2.79

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys11$7,259.002,975All Buys
Sells00--
1 monthBuys112$531,445.75217,627All Buys
Sells00--
2 monthsBuys122$1,515,094.24611,42319.01:1
Sells22$79,680.0032,000
3 monthsBuys122$1,515,094.24611,42319.01:1
Sells22$79,680.0032,000
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Jul 21, 2026
TANG KEVIN
10% Owner
Purchase2,975$2.44$7,259.00View Details
Jul 17, 2026
TANG KEVIN
10% Owner
Purchase265$2.44$646.60View Details
Jul 20, 2026
TANG KEVIN
10% Owner
Purchase1,623$2.44$3,960.12View Details
Jul 16, 2026
TANG KEVIN
10% Owner
Purchase18,491$2.44$45,118.04View Details
Jul 14, 2026
TANG KEVIN
10% Owner
Purchase43,878$2.43$106,623.54View Details
Jul 15, 2026
TANG KEVIN
10% Owner
Purchase1,600$2.44$3,904.00View Details
Jul 10, 2026
TANG KEVIN
10% Owner
Purchase43,367$2.43$105,381.81View Details
Jul 13, 2026
TANG KEVIN
10% Owner
Purchase48,211$2.42$116,670.62View Details
Jul 9, 2026
TANG KEVIN
10% Owner
Purchase7$2.48$17.36View Details
Jul 7, 2026
TANG KEVIN
10% Owner
Purchase15,810$2.48$39,208.80View Details
Jul 6, 2026
TANG KEVIN
10% Owner
Purchase27,062$2.49$67,384.38View Details
Jul 8, 2026
TANG KEVIN
10% Owner
Purchase14,338$2.46$35,271.48View Details
Jul 1, 2026
CRANDELL KEITH
10% Owner
Sale16,000$2.49$39,840.00View Details
Jul 1, 2026
ARCH Venture Fund IX, L.P.
10% Owner
Sale16,000$2.49$39,840.00View Details
Jul 1, 2026
TANG KEVIN
10% Owner
Purchase71,612$2.49$178,313.88View Details
Jul 2, 2026
TANG KEVIN
10% Owner
Purchase9,821$2.49$24,454.29View Details
Jun 30, 2026
TANG KEVIN
10% Owner
Purchase25,930$2.54$65,862.20View Details
Jun 30, 2026
TANG KEVIN
10% Owner
Purchase100$2.50$250.00View Details
Jun 25, 2026
TANG KEVIN
10% Owner
Purchase145,880$2.48$361,782.40View Details
Jun 26, 2026
TANG KEVIN
10% Owner
Purchase134$2.54$340.36View Details

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.7.3